| Literature DB >> 24885251 |
Sherifat O Lawani, Ellen W Demerath, Faye L Lopez, Elsayed Z Soliman, Rachel R Huxley, Kathryn M Rose, Alvaro Alonso1.
Abstract
BACKGROUND: Low birth weight (LBW) has been associated with an increased risk of cardiovascular disease (CVD). A previous study, however, found higher risk of atrial fibrillation (AF) in individuals with higher birth weight (BW). To further understand this apparent paradox, we examined the relationship between AF and BW in the Atherosclerosis Risk in Communities (ARIC) cohort.Entities:
Mesh:
Year: 2014 PMID: 24885251 PMCID: PMC4045869 DOI: 10.1186/1471-2261-14-69
Source DB: PubMed Journal: BMC Cardiovasc Disord ISSN: 1471-2261 Impact factor: 2.298
Number of excluded participants according to different exclusion criteria, ARIC study, 1996-1998
| Initial cohort in 1987-89 | | 15,792 |
| Attended visit 4 (1996–98) | 4,136 | 11,656 |
| Prevalent AF at visit 4 | 298 | 11,358 |
| Low or bad quality ECGs at baseline | 175 | 11,183 |
| Race other than white or African American | 67 | 11,116 |
| Missing Covariates | 151 | 10,965 |
| Twin gestation or premature infant | 490 | 10,475 |
| Missing BW | 343 | 10,132 |
Figure 1Causal model for the association of birth weight, as a proxy for intrauterine growth restriction, with the incidence of atrial fibrillation. The red-dashed line represents a hypothetical direct effect of intrauterine growth retardation on atrial fibrillation incidence not mediated through known cardiovascular risk factors. CVD: Cardiovascular disease. SES: Socioeconomic status.
Baseline characteristics of study participants by self-reported birth weight categories, ARIC study, 1996-2008
| | | |||
|---|---|---|---|---|
| N (%) | 449 (4%) | 8,597 (85%) | 1,086 (11%) | |
| Age, years (mean ± SD) | 62.7 ± 5.6 | 62.7 ± 5.7 | 62.8 ± 5.6 | 0.89 |
| Male, % | 22.1 | 42.6 | 59.1 | <0.001 |
| African American, % | 26.7 | 21.1 | 16.3 | <0.001 |
| Less than high school degree, % | 25.2 | 18.3 | 15.8 | <0.001 |
| BMI, kg/m2 (mean ± SD) | 28.5 ± 6.0 | 28.7 ± 5.5 | 29.4 ± 5.9 | 0.001 |
| Height, cm (mean ± SD) | 162.6 ± 8.6 | 168.2 ± 9.0 | 172.5 ± 9.1 | <0.001 |
| Diabetes, % | 19.8 | 15.8 | 14.6 | 0.04 |
| SBP, mmHg (mean ± SD) | 129.3 ± 19.1 | 127.4 ± 18.9 | 125.4 ± 18.0 | <0.001 |
| Hypertensive medication use, % | 47.4 | 42.4 | 39.2 | 0.01 |
| Current smoker, % | 17.8 | 14.2 | 17.3 | <0.001 |
| Prevalent heart failure, % | 1.3 | 1.3 | 2.2 | 0.06 |
| Prevalent myocardial infarction, % | 3.3 | 2.7 | 2.9 | 0.69 |
| Incident atrial fibrillation, % | 10.9 | 8.6 | 9.2 | 0.21 |
BMI: Body mass index; SBP: systolic blood pressure.
*P value based on chi square test for categorical variables and analysis of variance for continuous variables.
Hazard ratios and 95% confidence intervals of atrial fibrillation by birth weight category, ARIC study, 1996-2008
| | | |||
|---|---|---|---|---|
| AF events, N | 49 | 735 | 98 | |
| Person-years | 4,662 | 88,982 | 11,095 | |
| Incidence Rate* (95% CI) | 10.5 (7.9-13.8) | 8.3 (7.7-8.9) | 8.8 (7.2-10.7) | |
| Model 1 | 1.37 (1.03, 1.84) | 1 (ref.) | 1.00 (0.81, 1.23) | 0.21 |
| Model 2 | 1.33 (0.99, 1.78) | 1 (ref.) | 1.00 (0.81, 1.24) | 0.29 |
| Model 3 | 1.42 (1.06, 1.90) | 1 (ref.) | 0.86 (0.69, 1.07) | 0.01 |
*Incidence rate per 1000 person years.
Model 1: Cox proportional hazards model adjusted for age, race and gender.
Model 2: As model 1, additionally adjusted for study center, income, and education.
Model 3: As model 2, additionally adjusted for diabetes, systolic blood pressure, hypertension medications, smoking, height, body mass index, prevalent. myocardial infarction and heart failure.
Hazard ratios and 95% confidence intervals of atrial fibrillation by birth weight category, stratified by race, ARIC study, 1996-2008
| | | |||
|---|---|---|---|---|
| AF events, N | 38 | 624 | 81 | |
| Person-years | 3,471 | 70,183 | 9,304 | |
| Incidence Rate* (95% CI) | 10.9 (7.9-14.9) | 8.9 (8.2-9.6) | 8.7 (7.0-10.8) | |
| Model 1 | 1.35 (0.97, 1.88) | 1 (ref.) | 0.92 (0.73, 1.16) | 0.10 |
| Model 2 | 1.30 (0.94, 1.81) | 1 (ref.) | 0.92 (0.73, 1.16) | 0.13 |
| Model 3 | 1.38 (0.99, 1.92) | 1 (ref.) | 0.79 (0.63, 1.00) | 0.007 |
| | ||||
| AF events, N | 11 | 111 | 17 | |
| Person-years | 1,191 | 18,798 | 1,791 | |
| Incidence Rate* (95% CI) | 9.2 (4.9-16.0) | 5.9 (4.9-7.1) | 9.5 (5.7-14.9) | |
| Model 1 | 1.51 (0.81, 2.81) | 1 (ref.) | 1.64 (0.98, 2.74) | 0.55 |
| Model 2 | 1.49 (0.80, 2.78) | 1 (ref.) | 1.75 (1.04, 2.93) | 0.44 |
| Model 3 | 1.60 (0.86, 2.99) | 1 (ref.) | 1.37 (0.80, 2.34) | 0.97 |
*Incidence rate per 1000 person years.
Model 1: Cox proportional hazards model adjusted for age and gender.
Model 2: As model 1, additionally adjusted for study center, income, and education.
Model 3: As model 2, additionally adjusted for diabetes, systolic blood pressure, hypertension medications, smoking, height, body mass index, prevalent. myocardial infarction and heart failure.
Hazard ratio and 95% confidence intervals of atrial fibrillation by birth weight category, stratified by gender, ARIC study, 1996-2008
| | | |||
|---|---|---|---|---|
| AF events, N | 19 | 374 | 60 | |
| Person-years | 982 | 36,754 | 6,410 | |
| Incidence Rate* (95% CI) | 19.4 (12.0-29.6) | 10.2 (9.2-11.2) | 9.4 (7.2-12.0) | |
| Model 1 | 1.92 (1.21, 3.04) | 1 (ref.) | 0.92 (0.70, 1.20) | 0.07 |
| Model 2 | 1.91 (1.20, 3.03) | 1 (ref.) | 0.92 (0.70, 1.20) | 0.07 |
| Model 3 | 1.91 (1.20, 3.04) | 1 (ref.) | 0.80 (0.61, 1.06) | 0.009 |
| | ||||
| AF events, N | 30 | 361 | 38 | |
| Person-years | 3,680 | 52,227 | 4,685 | |
| Incidence Rate* (95% CI) | 8.2 (5.6-11.5) | 6.9 (6.2-7.7) | 8.1 (5.8-11.0) | |
| Model 1 | 1.17 (0.80, 1.69) | 1 (ref.) | 1.16 (0.83, 1.62) | 0.92 |
| Model 2 | 1.13 (0.78, 1.64) | 1 (ref.) | 1.17 (0.83, 1.63) | 0.80 |
| Model 3 | 1.23 (0.84, 1.79) | 1 (ref.) | 0.97 (0.67, 1.36) | 0.51 |
*Incidence rate per 1000 person years.
Model 1: Cox proportional hazards model adjusted for age and gender.
Model 2: As model 1, additionally adjusted for study center, income, and education.
Model 3: As model 2, additionally adjusted for diabetes, systolic blood pressure, hypertension medications, smoking, height, body mass index, prevalent. myocardial infarction and heart failure.